P634: Early-Stage Measurable Residual Disease Dynamics and Ighv Repertoire Reconstitution During Venetoclax and Obinutuzumab Treatment in Chronic Lymphocytic Leukemia

Abstract

Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.